U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900686) titled 'Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival' on March 23.

Brief Summary: This trial is a single-center retrospective study. Eligible patients receiving PD-1 inhibitor treatment will enrolled.

Study Start Date: March 20, 2013

Study Type: OBSERVATIONAL

Condition: Rectal Cancer Colon Cancer

Intervention: DRUG: PD1 Inhibitor

PD1 Inhibitor

Recruitment Status: COMPLETED

Sponsor: Yanhong Deng

Information provided by (Responsible Party): Yanhong Deng, Sun Yat-sen University

Published by HT Digital Content Services with permission from Health Daily Digest....